- Home
- GHI vs ENGN Comparison
GHI vs ENGN Comparison
Compare GHI & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- ENGN
- Stock Information
- Founded
- GHI 1998
- ENGN 1999
- Country
- GHI United States
- ENGN Canada
- Employees
- GHI N/A
- ENGN N/A
- Industry
- GHI Finance: Consumer Services
- ENGN
- Sector
- GHI Finance
- ENGN
- Exchange
- GHI Nasdaq
- ENGN Nasdaq
- Market Cap
- GHI 251.4M
- ENGN 317.6M
- IPO Year
- GHI N/A
- ENGN N/A
- Fundamental
- Price
- GHI $10.55
- ENGN $6.32
- Analyst Decision
- GHI Strong Buy
- ENGN Strong Buy
- Analyst Count
- GHI 4
- ENGN 9
- Target Price
- GHI $17.50
- ENGN $29.78
- AVG Volume (30 Days)
- GHI 126.6K
- ENGN 206.9K
- Earning Date
- GHI 02-20-2025
- ENGN 12-19-2024
- Dividend Yield
- GHI 14.03%
- ENGN N/A
- EPS Growth
- GHI N/A
- ENGN N/A
- EPS
- GHI 0.61
- ENGN N/A
- Revenue
- GHI $34,307,528.00
- ENGN N/A
- Revenue This Year
- GHI N/A
- ENGN N/A
- Revenue Next Year
- GHI $10.35
- ENGN N/A
- P/E Ratio
- GHI $17.20
- ENGN N/A
- Revenue Growth
- GHI 28.98
- ENGN N/A
- 52 Week Low
- GHI $10.32
- ENGN $4.42
- 52 Week High
- GHI $17.43
- ENGN $18.40
- Technical
- Relative Strength Index (RSI)
- GHI 35.80
- ENGN 36.76
- Support Level
- GHI $10.32
- ENGN $5.60
- Resistance Level
- GHI $11.05
- ENGN $6.54
- Average True Range (ATR)
- GHI 0.42
- ENGN 0.67
- MACD
- GHI -0.00
- ENGN -0.14
- Stochastic Oscillator
- GHI 19.01
- ENGN 22.43
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.